Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big Biotech: End of an Era
Seeking Alpha
Wednesday, July 28, 2010 - 10:17am
tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Genentech, Dendreon, Genzyme, Gilead Sciences, GSK, Roche, Human Genome Sciences, Vertex Pharmaceuticals, Sanofi
Transdel Pharma Stands to Gain From Pain Medication
Seeking Alpha
Wednesday, July 28, 2010 - 10:14am
tags:
Transdel, Ketotransdel
Antigenics: Bright Future Ahead
Seeking Alpha
Wednesday, July 28, 2010 - 10:13am
tags:
Antigenics
United Therapeutics back in black as revenue jumps 64%
Bizjournals.com
Wednesday, July 28, 2010 - 10:09am
tags:
United Therapeutics, earnings
Earnings Scorecard: Forest Labs
Yahoo/Zacks.com
Wednesday, July 28, 2010 - 10:08am
tags:
Forest Labs, earnings
Genzyme Giving Sanofi-Aventis the Cold Shoulder?
Seeking Alpha
Wednesday, July 28, 2010 - 10:06am
tags:
Genzyme, Sanofi, M&A, GSK, JNJ
Is Johnson & Johnson Really a Safety Stock?
Seeking Alpha
Wednesday, July 28, 2010 - 10:00am
tags:
JNJ, GSK, Novartis, Sanofi, AstraZeneca
Merck declares 38-cent regular quarter dividend
Yahoo/AP
Wednesday, July 28, 2010 - 9:56am
tags:
Merck, dividends
Merck Paid 3,468 Death Claims to Resolve Vioxx Suits
Bloomberg
Wednesday, July 28, 2010 - 12:53am
tags:
Merck, settlements, Vioxx
Dynavax starts universal flu vaccine test
Bizjournals.com
Wednesday, July 28, 2010 - 12:50am
tags:
Dynavax, Flu, vaccines
Better Buy: Cell Therapeutics or Sequenom?
Motley Fool
Wednesday, July 28, 2010 - 12:48am
tags:
Sequenom, Cell Therapeutics
Drug Company as Masochist: Bristol-Myers Takes Needless Whipping for HIV Drug Prices
BNET Pharma
Wednesday, July 28, 2010 - 12:45am
tags:
HIV, drug pricing, Bristol-Myers Squibb
Antigenics posts positive herpes drug study data
Yahoo/AP
Tuesday, July 27, 2010 - 8:39pm
tags:
Antigenics, genital herpes, herpes simplex 2
Cephalon second-quarter profit rises to $89 mln
Marketwatch
Tuesday, July 27, 2010 - 8:37pm
tags:
Cephalon, earnings
What Investors Think About Alexza Pharmaceuticals
Motley Fool
Tuesday, July 27, 2010 - 8:36pm
tags:
Alexza
Genzyme Could Go To $80, Says Analyst
CNBC
Tuesday, July 27, 2010 - 8:34pm
tags:
Genzyme, M&A, Sanofi
Five high-value biotech stocks to watch
Fierce Biotech
Tuesday, July 27, 2010 - 12:28pm
tags:
Array Biopharma, Alnylam, Rigel, OncoGenex, Infinity
Avandia's Exception
Forbes
Tuesday, July 27, 2010 - 12:25pm
tags:
Avandia, GSK, diabetes
Alcon Beats Easily; Raises Guidance
Yahoo/Zacks.com
Tuesday, July 27, 2010 - 11:48am
tags:
Alcon, earnings
Onyx Was Right to Acquire Proteolix All Along
Seeking Alpha
Tuesday, July 27, 2010 - 11:47am
tags:
ONYX Pharmaceuticals, Proteolix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.